罗亚军，刘音，薛晓艳. 乳酸清除率在感染性休克患者液体复苏中的应用—— 一项临床随机对照研究[J]. 中国急救医学, 2018, 38(6): 501-.
Luo Ya-jun, Liu Yin, Xue Xiao-yan. A clinical random control trial on the clearance of lactic acid in septic shock patients. Chinese Journal of Critical Care Medicine, 2018, 38(6): 501-.
［1］Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign： international guidelines for management of severe sepsis and septic shock, 2012［J］. Intensive Care Med, 2013, 39(2)：165-228.
［2］Martin GS, Mannino DM, Eaton S, et al. The epidemiology ofsepsis in the United States from 1979 through 2000［J］. N Engl J Med, 2003, 348(16)：1546-1554．
［3］周荣斌，周高速，郭凯，等．2018年严重脓毒症和脓毒性休克治疗指南简读［J］．中国急救医学， 2008， 28(3)：226-229．
［4］Smith SH, Perner A. Higher vs. lower fluid volume for septicshock：clinical characteristics and outcome in unselected patientsin a prospective，multicenter cohort［J］．Crit Care, 2012, 16(3)：R76．
［5］Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapyin〖JP〗 the treatment of severe sepsis and septic shock［J］. N Engl J Med, 2001, 345（19）：1368-1377.
［6］Peake SL, Delaney A, Bailey M, et al. Goal-directedresuscitation for patients with early septic shock［J］. N End J Med, 2014, 371(16)：1496-1506．
［7］Yealy DM， Kellum JA， Huang DT， et al. A randomized trial ofprotocol-based care for early septic shock［J］． N Engl J Med, 2014, 370(18)：1683-1693．
［8］Lin SM， Huang CD． A modified goal-directedprotocol improves clinical outcomes in intensive care unit patients with septic shock： a randomized controlled trial［J］． Shock， 2006， 26(6)：551-557．
［9］Wang xz， Lin CJ， Gao FQ， et al． Embay of goal-directed therapy in the treatment of septic shock［J］． Zhong Guo Wei ZhongBing Ji Jiu Yi xue， 2006， 18(11)：661_664．
［10］洪欢，彭松，张琳.早期乳酸清除率对脓毒症患者预后的评估［J］．临床急诊杂志, 2016, 16(12)：930-931．
［11］Cecconi M， De Backer D， Antonelli M，et al. Consensus oncirculatory shock and hemodynamic monitoring. Task force of theEuropean Society of Intensive Care Medicine［J］. Intensive Care Med， 2014， 40（12）：1795-1815.
［12］Arnold RC, Shapiro NI, Jones AE, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis［J］. Shock, 2009, 32（1）：35-39.
［13］Jones AE， Shapiro NI， Trzeciak S， et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy： therapy： a randomized clinical trial［J］. JAMA, 2010, 303（8）：739-746.
［14］韦丹, 王随力, 邓勇丽, 等．不同液体对脓毒性休克大鼠早期复苏效果比较［J］．实用儿科临床杂志， 2012， 27(23)：1801-1804．
［15］Mallat J, Michel D, Salaun P, et al. Defining metabolic acidosis in patients with septic shock using Stewart approach［J］. Am J Emerg Med, 2012, 30(3)：391-398．
［16］袁莹. 脓毒症液体复苏策略的现状与争议［J］. 中国急救医学, 2017, 37(4)：301-304．
［17］Delaney AP，Dan A，McCaffrey J，et al．The role of albumin as resuscitation fluid for patients with sepsis：a systematic review andmeta-analysis［J］．Crit Care Med， 2011， 39(2)：386-391．
［18］Caironi P, Tognoni G, Masson S, et al．Albumin replacement inpatients with severe sepsis or septic shock［J］. N Engl J Med, 2014, 370(15)：1412-1421．
［19］Roberts I， Blackhall K， Alderson P， et al. Human albumin solution for resuscitation and volume expansion in critically ill patients［J］. Cochrane Database Syst Rev，2011，9（11）：CD001208.
［20］Perel P， Roberts I. Colloids versus crystalloids for fluid resuscitation incritically ill patients［J］. Cochrane Database Syst Rev， 2012， 13（6）：CD000567.
［21］Caironi P, Tognoni G, Masson S, et al. Albumin replacement inpatients with severe sepsis or septic shock［J］. N Engl J Med， 2014, 370(15)：1412-1421．
